|
Ireland's weight loss journey
- The latest Irish GDP data provided the first full breakdown of the economy in Q2 2025. GDP growth remains volatile, driven by a surge in exports in the first half of the year.
- Other reliable domestic indicators point to continued growth in the Irish economy, including compensation of employees, up 2.2% y/y, in line with employment and wage growth in Q2 2025.
- As recently reported by the Wall Street Journal, this is likely originating from a new production line by Eli Lilly in Ireland feeding into its US supply chain for its blockbuster weight loss drug.
- Elsewhere, this week's exchequer returns also signaled ongoing growth in the Irish economy, with domestically driven VAT receipts up 4.8% in the year to end-August, while income taxes were up 4.7% over the same period.
|
|
